Please try another search
For the three months ended 31 March 2022, Biolog Device Co Ltd revenues increased 19% to W22.13B. Net income totaled W4.24B vs. loss of W3.7B. Revenues reflect OIS FPCB Assy segment increase of 56% to W18B, Other production segment increase from W410M to W1.07B, Vietnam (Country) segment increase of 28% to W20.37B, South Korea (Country) segment increase from W284.4M to W748.7M.
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Total Revenue | 41586.03 | 46576.88 | 27510.92 | 26250.32 |
Gross Profit | 1851.6 | 1433.99 | 809.51 | 2016.47 |
Operating Income | -400.78 | -2776 | -1192.38 | 265.97 |
Net Income | -880.28 | -8192.03 | -1697.87 | -233.76 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Total Assets | 108150.22 | 85226.66 | 82933.7 | |
Total Liabilities | 41158.15 | 50618.03 | 32378.45 | 33202.53 |
Total Equity | 57532.19 | 52848.21 | 49731.17 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | -1526.71 | 445.98 | 4882.56 | |
Cash From Investing Activities | 102.42 | -726.09 | 1571.7 | |
Cash From Financing Activities | 3216.44 | 580.47 | -5121.39 | |
Net Change in Cash | 1643.11 | 106.94 | 1539.38 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review